(Q48257794)

10 February 2018

title

Potential blood biomarker for disease severity in the Taiwanese population with Alzheimer's disease (English)

1 reference

10 February 2018

0 references

0 references

1 reference

Ching-Wen Huang

1

1 reference

10 February 2018

Shang-Jang Wang

2

1 reference

10 February 2018

Shyh-Jong Wu

3

1 reference

10 February 2018

Ching-Chung Yang

4

1 reference

10 February 2018

Ming-Wei Huang

5

1 reference

10 February 2018

Chieh-Hsin Lin

6

1 reference

10 February 2018

Irene H Cheng

7

1 reference

10 February 2018

language of work or name

English

0 references

publication date

10 December 2012

1 reference

10 February 2018

American Journal of Alzheimer's Disease & Other Dementias

published in

1 reference

10 February 2018

volume

28

1 reference

10 February 2018

issue

1

1 reference

10 February 2018

page(s)

75-83

1 reference

10 February 2018

Forecasting the global burden of Alzheimer’s disease

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1533317512467674

Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317512467674

Clinical and research diagnostic criteria for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317512467674

Core candidate neurochemical and imaging biomarkers of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317512467674

Biomarkers of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317512467674

Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317512467674

Plasma amyloid beta-protein and C-reactive protein in relation to the rate of progression of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317512467674

Plasma amyloid-beta as a biomarker in Alzheimer's disease: the AIBL study of aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317512467674

Maximizing the potential of plasma amyloid-beta as a diagnostic biomarker for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317512467674

Neuroinflammation: implications for the pathogenesis and molecular diagnosis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317512467674

A meta-analysis of cytokines in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317512467674

Copper, Zinc, and the Metallobiology of Alzheimer Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317512467674

Copper, beta-amyloid, and Alzheimer's disease: tapping a sensitive connection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317512467674

Serum zinc is decreased in Alzheimer's disease and serum arsenic correlates positively with cognitive ability

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317512467674

Serum zinc levels and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317512467674

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317512467674

Subclinical Zinc Deficiency in Alzheimer’s Disease and Parkinson’s Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317512467674

Zinc and inflammatory/immune response in aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317512467674

PBT2 rapidly improves cognition in Alzheimer's Disease: additional phase II analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317512467674

Reference values for the trace elements copper, manganese, selenium, and zinc in the serum/plasma of children, adolescents, and adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317512467674

Malnutrition in institutionalized elderly: how and why?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317512467674

Serum aluminium and zinc and other variables in patients with and without cognitive impairment in the community

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317512467674

Identification of peripheral inflammatory markers between normal control and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317512467674

Blood levels of histamine, IL-1 beta, and TNF-alpha in patients with mild to moderate Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317512467674

Is amyloidogenesis during Alzheimer's disease due to an IL-1-/IL-6-mediated 'acute phase response' in the brain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317512467674

Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317512467674

Peripheral Abeta subspecies as risk biomarkers of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317512467674

Plasma beta amyloid and the risk of Alzheimer disease and dementia in elderly men: a prospective, population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317512467674

Plasma ß-amyloid and cognitive decline

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317512467674

21 January 2018

Identifiers

DOI

10.1177/1533317512467674

1 reference

10 February 2018

1 reference

10 February 2018